Synapse - Virginia Klimek

Results (147)

A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients

Journal Article

Thoren, K. L.; Avecilla, S. T.; Klimek, V.; Goss, C.
Transfusion (2020)

Single-cell evaluation of myelodysplastic syndrome stem cells identifies determinants of hypomethylating agent response and a novel prognostic gene signature

Meeting Abstract

Javidiparsijani, S.; Dolgalev, I.; Vijay, P.; Gonzalez, M. D.; Devlin, S.; Klimek, V.; Chung, S.; Mason, C.; Park, C.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Preliminary results from a phase II study of the combination of pevonedistat and azacitidine in the treatment of MDS and MDS/MPN after failure of DNA methyltransferase inhibition

Meeting Abstract

Moyo, T. K.; Watts, J. M.; Skikne, B. S.; Mendler, J. H.; Klimek, V. M.; Chen, S. C.; Fan, R.; Anderson, I. A.; Sochacki, A.; Strickland, S. A.; more...
Blood (2019)

Fulltext@MSK | Save

Choice of hypomethylating agent (HMA) for initial treatment does not influence outcome or survival for therapy-related myeloid neoplasms (t-MN)

Meeting Abstract

Kabel, C. C.; Goldman, D. A.; Buie, L. W.; Klimek, V. M.
Blood (2019)

Fulltext@MSK | Save

Plasmacytoid dendritic cell proportion is predictive of risk and outcomes in myelodysplastic syndromes

Meeting Abstract

Chan, A.; Zhang, Y.; Devlin, S. M.; Lewis, N.; Baik, J.; Arcila, M. E.; Klimek, V. M.; Roshal, M.; Xiao, W.
Blood (2019)

Fulltext@MSK | Save

Results of a clinical trial of H3B-8800, a splicing modulator, in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML)